ABT-199-D10 is a deuterized form of ABT 199 (A112430), which is a potent and selective BCL-2 inhibitor that achieves potent antitumor activity while sparing platelets. Its practical application is to treat chronic lymphocytic leukaemic cells and estrogen receptor-positive breast cancer. Molecular Formula: C45H40D10ClN7O7S Molecular Weight: 878.5 Storage and Stability: Store at -20C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.
Molekulargewicht:
878.5
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
